Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL28043947

Clc1nc(Cl)nc(-c2ccccc2)n1.N.N.N.N.N.N.N.N.N.N.N

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
HTT P42858 1/20 0.58
ALDH1A1 P00352 5/20 0.56
HPGD P15428 4/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 3/20 0.54
KDM4E B2RXH2 2/20 0.54
GLA P06280 1/20 0.54
ADORA2A P29274 2/20 0.52
ADORA1 P30542 2/20 0.52
POLB P06746 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
ADORA2B P29275 1/20 0.52
MAPK1 P28482 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
TDP1 Q9NUW8 3/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18557130 1.00 MEN1 (0.58) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL782301 1.00 MEN1 (0.58) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL4031522 0.95 MEN1 (0.54) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL28243450 0.95 L3MBTL1 (0.58) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL106948 0.95 L3MBTL1 (0.58) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL18468590 0.90 L3MBTL1 (0.54) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL4201340 0.90 L3MBTL1 (0.54) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL18468613 0.90 L3MBTL1 (0.54) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL16332656 0.90 L3MBTL1 (0.54) MEN1KMT2AHTTALDH1A1HPGD
SCHEMBL29385431 0.90 L3MBTL1 (0.54) MEN1KMT2AHTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105492435-A N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer AGIOS PHARMACEUTICALS INC 2016-04-13 CN disclosed